Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share (YMAB)

131 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share as of Q1 2021.
Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share (YMAB) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26.3M shares of 45.1M outstanding shares and own 58.36% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.02M shares), BlackRock Inc. (2.52M shares), Sofinnova Investments, Inc. (2.19M shares), STATE STREET CORP (1.71M shares), VANGUARD GROUP INC (1.6M shares), FMR LLC (1.55M shares), Artisan Partners Limited Partnership (1.32M shares), ALLIANCEBERNSTEIN L.P. (1.23M shares), Cormorant Asset Management, LP (1.23M shares), and First Light Asset Management, LLC (944K shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.